Loading clinical trials...
Loading clinical trials...
To describe the outcome of patients with anaplastic thyroid cancer treated with hyperfractionated radiotherapy and concomitant chemotherapy
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Alberta Health services
NCT06374602 · Anaplastic Thyroid Cancer
NCT03085056 · Anaplastic Thyroid Cancer
NCT04238624 · Anaplastic Thyroid Cancer, Thyroid Cancer, and more
NCT04420754 · Anaplastic Thyroid Cancer, Relapsed/Refractory Poorly Differentiated Thyroid Cancer
NCT07485569 · Thyroid Cancer Stage IV, Anaplastic Thyroid Cancer, and more
Tom Baker Cancer Centre
Calgary, Alberta
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions